EFCG calls on policymakers to decisively imbed Contract Development and Manufacturing Organizations (CDMOs) within the Biotech Act’s implementation roadmap. This is essential to secure Europe’s leadership in biopharmaceutical innovation and to fortify the resilience of our supply chains.

Read more in this article.